Comparison of two proliferation assays MTT and ltt in immunodeficient patients

Anna Isaian1, Zahra Pourpak, Laleh Nikfarjam

  • 1Department of Immunology and Allergy, Children Medical Center, Thhran University of Medical Sciences, Tehran, Iran.

Insights

The MTT assay offers a sensitive, non-radioactive method for quantifying cell proliferation, showing high correlation with the LTT assay in immunodeficient patients. This makes MTT a preferable choice for cell viability assessment.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Cell proliferation assays are crucial for assessing immune function.
  • The MTT assay provides a non-radioactive method for quantifying cell growth and viability.
  • Comparing the sensitivity of MTT and lymphocyte transformation test (LTT) is important for immunodeficient patient evaluation.

Purpose of the Study:

  • To compare the sensitivity of the MTT assay and the LTT assay in evaluating lymphocyte proliferation.
  • To assess the utility of the MTT assay as a non-radioactive alternative for cell proliferation studies in immunodeficient individuals.

Main Methods:

  • The study involved 20 immunodeficient patients and 20 healthy controls with normal lymphocyte counts and CD3 levels.
  • Lymphocytes were stimulated with phytohemagglutinin (PHA) as a mitogen.
  • Cell proliferation was evaluated using both the MTT assay and the LTT assay.

Main Results:

  • Both MTT and LTT assays demonstrated a strong correlation in measuring lymphocyte proliferation between immunodeficient patients and healthy controls.
  • The sensitivity of the MTT assay was found to be 90%, while the LTT assay showed a sensitivity of 98%.
  • MTT assay is a reliable non-radioactive method for cell proliferation evaluation.

Conclusions:

  • The MTT assay is a sensitive and reliable method for assessing cell proliferation, comparable to the LTT assay.
  • MTT assay offers a safe, fast, and accurate alternative to LTT for evaluating cell proliferation, particularly in clinical settings involving immunodeficient patients.

Related Concept Videos